What fibrinogen level cutoff is used to diagnose disseminated intravascular coagulation (DIC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fibrinogen Cutoff for DIC Diagnosis

The fibrinogen cutoff for diagnosing overt DIC using the ISTH criteria is <100 mg/dL (or <1 g/L), which scores 1 point in the diagnostic algorithm. 1

ISTH Overt DIC Scoring System

The International Society on Thrombosis and Haemostasis (ISTH) overt DIC criteria use fibrinogen as one component of a multi-parameter scoring system 1:

  • Fibrinogen <100 mg/dL = 1 point
  • Total DIC score ≥5 indicates overt DIC

The complete scoring includes:

  • Platelet count (0-2 points)
  • PT prolongation (0-2 points)
  • FDP/D-dimer elevation (0-3 points)
  • Fibrinogen <100 mg/dL (1 point)

Important Context and Caveats

Sepsis-Induced Coagulopathy (SIC) Does Not Use Fibrinogen

For sepsis-associated DIC, the newer SIC criteria intentionally exclude fibrinogen because hypofibrinogenemia is uncommon in sepsis-associated coagulopathy 1. Sepsis-induced DIC typically presents with suppressed fibrinolysis and a thrombotic phenotype rather than consumptive hypofibrinogenemia. The SIC score focuses on platelet count, PT ratio, and SOFA score instead.

Clinical Significance of Higher Fibrinogen Thresholds

While the ISTH cutoff is <100 mg/dL, mortality risk increases sharply when fibrinogen drops below 200 mg/dL in septic patients 2. Additionally:

  • In trauma-associated DIC with fibrinolytic phenotype, fibrinogen <190 mg/dL predicts both mortality and massive bleeding 3
  • Some researchers recommend modifying the ISTH cutoff to 150 mg/dL with a 2-point score for levels <100 mg/dL to improve diagnostic concordance 4

DIC Phenotype Matters

The fibrinogen level behaves differently depending on DIC phenotype 5:

  • Thrombotic phenotype (common in sepsis): Fibrinogen may be normal or elevated initially due to acute phase response
  • Fibrinolytic/hemorrhagic phenotype (trauma, malignancy, obstetrics): Marked hypofibrinogenemia due to consumption and pathologic fibrinogenolysis

In fibrinolytic DIC, look for:

  • Low fibrinogen (<200 mg/dL)
  • Elevated FDP/D-dimer ratio (suggests fibrinogenolysis rather than just fibrinolysis)
  • Massive bleeding rather than thrombosis 3, 5

2025 Updated ISTH Criteria

The most recent 2025 ISTH update maintains the <100 mg/dL fibrinogen threshold for overt DIC scoring but emphasizes disease-specific approaches 6. The updated framework recognizes that fibrinogen cutoffs should be interpreted in context of the underlying condition and DIC phenotype.

Practical Algorithm

  1. Suspect DIC based on underlying condition (sepsis, trauma, malignancy, obstetric emergency)
  2. Calculate ISTH overt DIC score using fibrinogen <100 mg/dL as 1 point
  3. If sepsis-related, use SIC criteria instead (no fibrinogen component)
  4. If fibrinogen 100-200 mg/dL with bleeding, consider early/evolving DIC even if score <5
  5. Assess phenotype: Low fibrinogen + high FDP/D-dimer ratio suggests fibrinolytic DIC requiring different management (consider tranexamic acid) 5, 7

Related Questions

Can prolonged courses of rifampin or doxycycline cause bone‑marrow toxicity or disseminated intravascular coagulation?
How should a patient with hemoperitoneum and disseminated intravascular coagulation (DIC) be managed?
Compare and contrast Disseminated Intravascular Coagulation, Sepsis‑Induced Coagulopathy, and Trauma‑Induced Coagulopathy, describing each condition’s pathophysiological drivers, the recommended diagnostic scoring systems (e.g., International Society on Thrombosis and Haemostasis criteria), and evidence‑based thresholds for anticoagulation versus blood product administration.
When should I order a quantitative D‑dimer test and what cutoff values should I use to rule out venous thromboembolism or disseminated intravascular coagulation?
Can aspiration pneumonia lead to disseminated intravascular coagulation (DIC)?
What are the evaluation steps, surgical procedure, risks, and recovery process for living donor liver donation?
Can a patient with extensively drug‑resistant tuberculosis on delamanid, bedaquiline, cycloserine, and moxifloxacin safely undergo liver transplantation for cirrhosis?
Is alprostadil (prostaglandin E1) useful for systemic sclerosis-associated pulmonary arterial hypertension (SSc‑PAH)?
In a patient with end‑stage renal disease on hemodialysis who has persistent congestion, global left‑ventricular hypokinesia, and uncontrolled hypertension despite an angiotensin‑receptor blocker (ARB) and a calcium‑channel blocker (CCB), should nitrates be added?
What is the role of a pulmonologist in lung transplantation?
How should proteinuria be managed in a 40-year-old woman at 22 weeks gestation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.